Some successful rheumatoid arthritis therapies may help us better understand how to treat people with mosquito-borne viral diseases.
Griffith University viral immunologist Professor Suresh Mahalingam has been appointed to a World Health Organization (WHO) advisory group tasked with combatting viruses like dengue and Zika.
Dr Lara Herrero, research leader at Griffith University’s Institute for Glycomics, has been honoured with the Creating Change Award at...
Griffith University has been named as a Global Virus Network Centre of Excellence, one of three in Australia.
The threat of mosquito-borne outbreaks of emerging viruses will be tackled by the newly-established Research Group for Emerging Viruses, Inflammation and Therapeutics.
Scientists have discovered a way that could help treat severe inflammation from an infectious mosquito-borne disease during outbreaks. A team...
Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment in the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus and Chikungunya Virus.
By Suresh Mahalingam, Principal Research Leader, Institute for Glycomics As Zika fear rises, especially in the wake of the World...
Griffith University and an international team of researchers have moved a step closer to identifying a broad spectrum treatment for the dreaded arthritogenic alphavirus infections.
Underlying evolutionary dynamics could play a key role in the replication and progress of the chikungunya virus, a mosquito-borne viral disease.
